CS logo
small CS logo
Via Christi Regional Medical Center

Wichita, Kansas, United States
Doctor in Wichita, Kansas
1100 N St Francis St, Wichita, KS 67214

About Via Christi Regional Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
45
SWOG Cancer Research Network
25
Alliance for Clinical Trials in Oncology
11
Children's Oncology Group
11
Gynecologic Oncology Group
7
ECOG-ACRIN Cancer Research Group
4
Boston Scientific Corporation
3
Exact Sciences Corporation
2
Leonard-Meron Biosciences, Inc.
2
Merrimack Pharmaceuticals
2
NRG Oncology
2
Total Rows: 27

Clinical Trials at Via Christi Regional Medical Center


During the past decade, Via Christi Regional Medical Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 73 clinical trials were completed, i.e. on average, 486.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 23 clinical trials were completed. i.e. 1150% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years66112222221100117714141010771212559977Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
1994-09-01
2007-03-01
Completed
31
Interferon Alfa in Treating Children With HIV-Related Cancer
1994-12-01
2005-09-01
Completed
8
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
1996-01-01
Completed
156
Topotecan in Treating Children With Refractory Leukemia
1996-04-01
Completed
3
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma
1996-09-01
2006-04-01
Completed
43
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
1996-12-01
2011-01-01
Completed
421
Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
1998-11-01
2008-03-01
Completed
53
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
1998-10-01
2004-10-01
Completed
1,691

Rows per page:

1–100 of 134

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Via Christi Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 45 trials, followed by "SWOG Cancer Research Network" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "Children's Oncology Group" with 11 trials sponsored and "Gynecologic Oncology Group" with 11 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 27 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Via Christi Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 64 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 27 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 45National CancerInstitute (NCI): 45SWOG Cancer ResearchNetwork: 25SWOG Cancer ResearchNetwork: 25Alliance for ClinicalTrials in Oncology: 11Alliance for ClinicalTrials in Oncology: 11Children's Oncology Group: 11Children's Oncology Group: 11Gynecologic Oncology Group: 7Gynecologic Oncology Group: 7ECOG-ACRIN CancerResearch Group: 4ECOG-ACRIN CancerResearch Group: 4Boston Scientific Corporation: 3Boston Scientific Corporation: 3Exact Sciences Corporation: 2Exact Sciences Corporation: 2Leonard-MeronBiosciences, Inc.: 2Leonard-MeronBiosciences, Inc.: 2Merrimack Pharmaceuticals: 2Merrimack Pharmaceuticals: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 64National CancerInstitute (NCI): 64NRG Oncology: 9NRG Oncology: 9NCIC Clinical Trials Group: 6NCIC Clinical Trials Group: 6Cancer and LeukemiaGroup B: 3Cancer and LeukemiaGroup B: 3Eastern CooperativeOncology Group: 3Eastern CooperativeOncology Group: 3Radiation TherapyOncology Group: 3Radiation TherapyOncology Group: 3North Central CancerTreatment Group: 2North Central CancerTreatment Group: 2SWOG Cancer ResearchNetwork: 2SWOG Cancer ResearchNetwork: 2AstraZeneca: 1AstraZeneca: 1Breast International Group: 1Breast International Group: 1

Clinical Trials Conditions at Via Christi Regional Medical Center


According to Clinical.Site data, the most researched conditions in "Via Christi Regional Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Colorectal Cancer" (8 trials), "Breast Cancer" (7 trials), "Leukemia" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Via Christi Regional Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Via Christi Regional Medical Center


Most popular intervention types in "Via Christi Regional Medical Center" are "Drug" (108 trials), "Other" (64 trials), "Biological" (38 trials), "Procedure" (19 trials) and "Radiation" (18 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "Quality-of-Life Assessment" (16 trials), "Placebo" (13 trials), "Paclitaxel" (12 trials) and "leucovorin calcium" (10 trials). Other intervention names were less common.

Clinical Trials Genders at Via Christi Regional Medical Center


The vast majority of trials in "Via Christi Regional Medical Center" are 102 trials for "All" genders, 29 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at Via Christi Regional Medical Center


Currently, there are NaN active trials in "Via Christi Regional Medical Center". undefined are not yet recruiting, 3 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 89 completed trials in Via Christi Regional Medical Center, undefined suspended trials, and 17 terminated clinical trials to date.
Out of the total trials that were conducted in Via Christi Regional Medical Center, 9 "Phase 1" clinical trials were conducted, 63 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 63Phase 2: 63Phase 3: 52Phase 3: 52Phase 1: 9Phase 1: 9Not Applicable: 7Not Applicable: 7

Created with Highcharts 11.1.0Trials StatusCompleted: 89Completed: 89Active, not recruiting: 19Active, not recruiting: 19Terminated: 17Terminated: 17Unknown status: 4Unknown status: 4Recruiting: 3Recruiting: 3Available: 1Available: 1No longer available: 1No longer available: 1